Molecular Evidence for a Link between the N363S Glucocorticoid Receptor Polymorphism and Altered Gene Expression
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
CONTEXT: A single-nucleotide polymorphism (SNP) in the human glucocorticoid receptor (hGR) N363S (rs6195) has been the focus of several clinical studies, and some epidemiological data link this SNP to increased glucocorticoid sensitivity, coronary artery disease, and increased body mass index. However, molecular studies in vitro using reporter gene expression systems have failed, for the most part, to define a link between this polymorphism and altered glucocorticoid receptor function. OBJECTIVE: The objective of this study was to address the biological relevancy of N363S SNP in GR function by establishing stable U-2 OS (human osteosarcoma) cell lines expressing wild-type hGR or N363S and examining these receptors under a variety of conditions that probe for GR activity including human gene microarray analysis. DESIGN: Functional assays with reporter gene systems, Western blotting, and human microarray analysis were used to evaluate the activity of wild-type and N363S GR in both transiently and stably expressing cells. In addition, quantitative RT-PCR was used to confirm the microarray analysis. RESULTS: Functional assays with reporter gene systems and homologous down-regulation revealed only minor differences between the wild-type hGR and N363S receptors in both transiently and stably expressing cell lines. However, examination of the two receptors by human gene microarray analysis revealed a unique gene expression profile for N363S. CONCLUSIONS: These studies demonstrate that the N363S SNP regulates a novel set of genes with several of the regulated genes supporting a potential role for this GR polymorphism in human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“results in modest increases in GR transcriptional activity”
From Corticosteroids (2016) · cites this paper as [84]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and is associated with generalized increases in glucocorticoid sensitivity.”
From Corticosteroids (2016) · cites this paper as [84]
Experimental — accuracy not yet measuredIn the citing paper
“N363S carriers have been reported to have an increased body mass index, coronary artery disease and decreased bone mineral density84.”
From Corticosteroids (2016) · cites this paper as [84]
In the citing paper
“The N363S polymorphism, located within exon 2 (Fig.3C), occurs in ~4% of the population”
From Corticosteroids (2016) · cites this paper as [84]
In the citing paper
“N363S carriers have been reported to have an increased body mass index, coronary artery disease and decreased bone mineral density84.”
From Corticosteroids (2016) · cites this paper as [84]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288 · cited 1×
“gov/geo/) (25) and is accessible through GEO accession no.”
BackgroundAntiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 1×
“Although most cortisol is bound to corticosteroid-binding globulin in the blood, approximately 10% remains free and is the biologically active form of the hormone (1).”
BackgroundSelf-citationRosmond, R., Dallman, M. F., & Björntorp, P. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4843 · Cited by 871
Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819
Self-citationRosmond, R. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1853 · Cited by 590
Lu, N. Z., & Cidlowski, J. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.025 · Cited by 455 · cited 11×
“Second, we generated stable human cell lines expressing either wild-type hGR or the N363S polymorphism by stably transfecting the receptors into U-OFF cells (U-2 OS cells, human osteosarcoma), which do not have detectable levels of GR (23).”
BackgroundMethodSelf-citationMcKay, L. I., & Cidlowski, J. A. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.1.0044 · Cited by 405 · cited 1×
“The ability of the GR to repress the action of the proin-flammatory cytokine, signal transduction mediator nuclear factor-κB (NF-κB) is well known (26,27).”
BackgroundSelf-citationWüst, S., van Rossum, E. F. C., Federenko, I. S., Koper, J. W., Kumsta, R., & Hellhammer, D. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031148 · Cited by 348 · cited 1×
“In addition, a study using the Trier Social Stress Test, which assesses cortisol and ACTH responses to psychosocial stress, showed that N363S carriers had significantly increased salivary cortisol responses to stress (7).”
MethodModulation of Glucocorticoid Receptor Function via Phosphorylation
ISMAILI, N., & GARABEDIAN, M. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1321.007 · Cited by 318 · cited 1×
“In addition, the amino acid sequences surrounding the serine site do not correspond to the published consensus sequence (30).”
BackgroundHuizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.144 · Cited by 265 · cited 5×
“Interestingly, these carriers exhibited an increased sensitivity to exogenously administered glucocorticoids as well as an increased insulin response and increased body mass index (BMI) ( 6 ).”
BackgroundResultInfluentialWebster, J. C., Jewell, C. M., Bodwell, J. E., Munck, A., Sar, M., & Cidlowski, J. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9287 · Cited by 261
Self-citationGlucocorticoid receptor variants: clinical implications
DeRijk, R. H., Schaaf, M., & de Kloet, E. R. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00062-6 · Cited by 251 · cited 1×
“metabolism as well as the cardiovascular system, the immune system, behavior, bone density, and cell growth in addition to the regulation of the HPA axis itself (2).”
BackgroundHuizenga, N. A. T. M., Koper, J. W., de Lange, P., Pols, H. A. P., Stolk, R. P., Grobbee, D. E., de Jong, F. H., & Lamberts, S. W. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4498 · Cited by 250
Karl, M., Lamberts, S. W., Detera-Wadleigh, S. D., Encio, I. J., Stratakis, C. A., Hurley, D. M., Accili, D., & Chrousos, G. P. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445027 · Cited by 241 · cited 4×
“These results support most of the previous reports (5,6,20,21), although recently Russcher et al.”
BackgroundResultInfluentialSex differences in the relation of body composition to markers of inflammation
Thorand, B., Baumert, J., Döring, A., Herder, C., Kolb, H., Rathmann, W., Giani, G., & Koenig, W. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.011 · Cited by 233 · cited 1×
“Although CRP and IL-6 have been previously associated with parameters of obesity, only recently has SAA also been investigated in relation to body composition (32).”
BackgroundRusscher, H., Smit, P., van den Akker, E. L. T., van Rossum, E. F. C., Brinkmann, A. O., de Jong, F. H., Lamberts, S. W. J., & Koper, J. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0646 · Cited by 199
Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition
Poitou, C., Viguerie, N., Cancello, R., De Matteis, R., Cinti, S., Stich, V., Coussieu, C., Gauthier, E., Courtine, M., Zucker, J. D., et al. (2005) · Diabetologia · doi:10.1007/s00125-004-1654-6 · Cited by 180 · cited 10×
“In all three of these studies, weight loss whether by diet (33,34) or gastric bypass (35) was associated with a significant decrease in SAA.”
BackgroundInfluentialHuizenga, N. A. T. M. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.1.47 · Cited by 173
Di Blasio, A. M., Van Rossum, E. F. C., Maestrini, S., Berselli, M. E., Tagliaferri, M., Podestà, F., Koper, J. W., Liuzzi, A., & Lamberts, S. W. J. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01798.x · Cited by 143
Cidlowski, J. A., Bellingham, D. L., Powell-Oliver, F. E., Lubahn, D. B., & Sar, M. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-10-1427 · Cited by 139 · cited 2×
“57 (1:1000) and anti-β-actin (Chemicon, Temecula, CA) (1:10,000) for 1 h at room temperature (24).”
BackgroundSelf-citationDobson, M. G., Redfern, C. P. F., Unwin, N., & Weaver, J. U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7465 · Cited by 132 · cited 1×
“(13) also showed an association with increased waist-to-hip ratio in male N363S carriers but no associations with BMI, blood pressure, or serum cholesterol levels.”
BackgroundO’Brien, K. D., Brehm, B. J., Seeley, R. J., Bean, J., Wener, M. H., Daniels, S., & D’Alessio, D. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1011 · Cited by 130 · cited 9×
“In all three of these studies, weight loss whether by diet (33,34) or gastric bypass (35) was associated with a significant decrease in SAA.”
BackgroundInfluentialIncreased Serum Amyloid A Concentrations in Morbid Obesity Decrease after Gastric Bypass
Gómez-Ambrosi, J., Salvador, J., Rotellar, F., Silva, C., Catalán, V., Rodríguez, A., Jesús Gil, M., & Frühbeck, G. (2006) · Obesity Surgery · doi:10.1381/096089206776116525 · Cited by 119 · cited 10×
“In all three of these studies, weight loss whether by diet (33,34) or gastric bypass (35) was associated with a significant decrease in SAA.”
BackgroundInfluentialde Lange, P. (1997) · Molecular Endocrinology · doi:10.1210/me.11.8.1156 · Cited by 117 · cited 3×
“These results support most of the previous reports (5,6,20,21), although recently Russcher et al.”
BackgroundResultHigh penetrance, overweight, and glucocorticoid receptor variant: case-control study
Lin, R. C. Y., Wang, W. Y. S., & Morris, B. J. (1999) · BMJ · doi:10.1136/bmj.319.7221.1337 · Cited by 116 · cited 11×
“A study by Roussel et al. (12) on French subjects with type 2 diabetes mellitus also reported an increase in BMI in subjects carrying the N363S polymorphism.”
BackgroundMethodInfluentialAssociation of Coronary Artery Disease With Glucocorticoid Receptor N363S Variant
Lin, R. C. Y., Wang, X. L., & Morris, B. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000055342.40301.dc · Cited by 106 · cited 16×
“In a separate study by Lin et al. (10) on subjects of Anglo-Celtic descent with coronary artery disease (CAD), they reported that the frequency of the S363 allele was 0.04 in a healthy normal-weight control group but rose to 0.15 in patients with CAD.”
BackgroundMethodInfluentialSerum amyloid A: The “other” inflammatory protein
O’Brien, K. D., & Chait, A. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0066-0 · Cited by 100
Association studies of genetic polymorphisms in central obesity: a critical review
Rosmond, R. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802397 · Cited by 86
Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant
Lin, R. C. Y., Wang, X. L., Dalziel, B., Caterson, I. D., & Morris, B. J. (2003) · Obesity Research · doi:10.1038/oby.2003.111 · Cited by 83 · cited 1×
“(8,9) confirmed this association of increased BMI with the N363S polymorphism.”
BackgroundDobson, M. G. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2270 · Cited by 81
Roussel, R., Reis, A. F., Dubois‐Laforgue, D., Bellanné‐Chantelot, C., Timsit, J., & Velho, G. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01831.x · Cited by 72 · cited 11×
“A study by Roussel et al. (12) on French subjects with type 2 diabetes mellitus also reported an increase in BMI in subjects carrying the N363S polymorphism.”
BackgroundMethodInfluentialGaitan, D., DeBold, C. R., Turney, M. K., Zhou, P., Orth, D. N., & Kovacs, W. J. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.9.7491111 · Cited by 67 · cited 3×
“These results support most of the previous reports (5,6,20,21), although recently Russcher et al.”
BackgroundResultEchwald, S. M., Sørensen, T. I. A., Andersen, T., & Pedersen, O. B. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801744 · Cited by 59
ACUTE PHASE SERUM AMYLOID A, CHOLESTEROL METABOLISM, AND CARDIOVASCULAR DISEASE
Kisilevsky, R., & Tam, S. (2002) · Fetal and Pediatric Pathology · doi:10.1080/02770930290056523 · Cited by 47
Syed, A. A., Irving, J. A. E., Redfern, C. P. F., Hall, A. G., Unwin, N. C., White, M., Bhopal, R. S., Alberti, K. G. M. M., & Weaver, J. U. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030995 · Cited by 38 · cited 2×
“Low prevalence of the N363S polymorphism of the glucocorticoid receptor in South Asians living in the United Kingdom.”
BackgroundPrognostic Value of Serum Amyloid A Protein in Patients With Acute Myocardial Infarction
Katayama, T., Nakashima, H., Takagi, C., Honda, Y., Suzuki, S., Iwasaki, Y., & Yano, K. (2005) · Circulation Journal · doi:10.1253/circj.69.1186 · Cited by 32 · cited 1×
“This has led to SAA being investigated as a prognostic indicator, along with CRP, for acute myocardial infarction (31).”
BackgroundACUTE PHASE SERUM AMYLOID A, CHOLESTEROL METABOLISM, AND CARDIOVASCULAR DISEASE
Kisilevsky, R., & Tam, S. (2002) · Fetal and Pediatric Pathology · doi:10.1080/pdp.21.3.291.305 · Cited by 24 · cited 4×
“Interestingly, the serum amyloid A (SAA) family of proteins, which are increased in plasma concentration during acute inflammatory reactions and involved in cholesterol metabolism (28) and includes SAA1, SAA2, and SAA4, were among some of the genes highly up-regulated by the N363S polymorphism but were unaffected by d…”
BackgroundInfluentialIKEDA, Y., SUEHIRO, T., TSUZURA, S., SHIINOKI, T., KANEDA, T., KUMON, Y., & HASHIMOTO, K. (2001) · Endocrine Journal · doi:10.1507/endocrj.48.723 · Cited by 19 · cited 1×
“Interestingly, the N363S variant did not occur in Japanese subjects (18) and was of extremely low prevalence in a study performed on South Asians living in the United Kingdom (19).”
BackgroundThe N363S Polymorphism of the Glucocorticoid Receptor and Metabolic Syndrome Factors in Men
Buemann, B., Black, E., Holst, C., Toubro, S., Echwald, S., Pedersen, O., Astrup, A., & Sørensen, T. (2005) · Obesity Research · doi:10.1038/oby.2005.99 · Cited by 16 · cited 1×
“(17) have shown no association between N363S and increased BMI.”
Background
Research works printed but not linked: 1
- Halsall DJ, Luan J, Hales N, Wareham NJ, O’Rahilly S. Glucocorticoid receptor variant and body mass index. Rapid Response to BMJ. 2000;7221:1337–1338. [Google Scholar]
Cited by
The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease
Oakley, R. H., & Cidlowski, J. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.007 · Cited by 1,068
“In addition, a genome-wide microarray analysis has revealed a unique pattern of gene regulation for the N363S polymorphism (52).”
BackgroundSelf-citationRamamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Self-citationGlucocorticoid sensitivity in health and disease
Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W. J., van Rossum, E. F. C., & Feelders, R. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.183 · Cited by 310
Clinical Features Associated with Glucocorticoid Receptor Polymorphisms: An Overview
Manenschijn, L., van den Akker, E. L. T., Lamberts, S. W. J., & van Rossum, E. F. C. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05013.x · Cited by 249
Corticosteroid receptor polymorphisms: Determinants of vulnerability and resilience
DeRijk, R. H., & de Kloet, E. R. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.072 · Cited by 184
Metadata
- Authors
- Jewell, C. M., & Cidlowski, J. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-08-01
- Volume
- 92
- Issue
- 8
- Pages
- 3268-3277
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC2692663
- OpenAlex
- W2015357735
- Cited by
- 60
- References
- 39
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 7 · 2015: 2 · 2014: 3 · 2013: 8 · 2012: 3
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Environmental Health Sciences (Z01ES090057)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- glucocorticoid receptor, N363S polymorphism, single nucleotide polymorphisms, gene expression profiling, glucocorticoid sensitivity, coronary artery disease, body mass index, U2OS cells, receptor function
- MeSH terms
- Animals, Chlorocebus aethiops, Dexamethasone, Humans, Genetic Linkage, Polymorphism, Genetic, Receptors, Glucocorticoid, Osteosarcoma, Transfection, Blotting, Western, Gene Expression, Genes, Reporter, COS Cells, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Polymorphism, Single Nucleotide, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.